iof_wco_logo.gif

Would you like to learn more about IOF and its activities?
Visit the IOF website

History of the IOF WCO

Second announcement
Download final announcement (PDF, 1.6 MB, 28 pages)

Download the powerpoint slide announcing the congress (PowerPoint, 638 KB)

Satellite Symposia Program

Friday, June 2, 2006

16:30 – 18:00

THEATRE
(ROOM A)

Clinical Management of Osteoporosis

Satellite Symposium presented by
ELI LILLY
Chair: D. GOLTZMAN

Quality of Life in Patients with Osteoporosis: Assessment of Pain and Function
J.D. ADACHI

Maximizing Adherence to Osteoporosis Therapies
D.A. HANLEY

Future Directions in Osteoporosis Therapy: Nonvertebral Fracture Outcomes and Long-term Fracture Risk Assessment
P.D. DELMAS

Saturday June 3, 2006

07:00 – 08:30

THEATRE
(ROOM A)

Improving Osteoporosis Therapy: A Logical Progression

Special Breakfast Symposium presented by
MSD
Chair: D. HOSKING

Opening Remarks

Patients First
A. SEBBA

Vitamin D: Understanding the Importance
B. DAWSON-HUGHES

A Better Approach to Osteoporosis Patient Care
S. EPSTEIN

Panel Discussion/Q&A
16:15 – 17:45

CONSTITUTION HALL
(ROOM B)

Expanding the Clinical Picture of Osteoporosis

Satellite Symposium presented by
THE ALLIANCE FOR BETTER BONE HEALTH
Chair: P.D. DELMAS

The Undiagnosed and Untreated Patient
P.D. DELMAS

Current Challenges in Male Osteoporosis
S. BOONEN

Beyond the Spine: The Importance of Diagnosing and Treating Nonvertebral Fractures
J. ADACHI
16:15 – 17:45

THEATRE
(ROOM A)

Effective Management of Postmenopausal Osteoporosis with Less Frequent Dosing

Satellite Symposium presented by
ROCHE/GSK
Chair: J.Y. REGINSTER

Poor Adherence is Widespread in Clinical Practice and Compromises Patient Outcomes
P. HADJI

Patients' Preference for Once-monthly Ibandronate: The Evidence
M.L. BRANDI

Once-monthly Ibandronate: Meeting Patients' Needs with Efficacy, Safety and Tolerability
M. STONE

Once-monthly Ibandronate: Experience from Clinical Practice
P. HADJI

Options When Oral Dosing is Unsuitable: Intravenous Bisphosphonates
R.R. RECKER

Summary – Expanding Bisphosphonate Treatment Options to Meet Both Physician and Patient Needs
J.Y. REGINSTER

Questions and Answers

Sunday June 4, 2006

07:00 – 08:30

THEATRE
(ROOM A)

A New Pathway to Bone Health: Emerging Therapeutic Options

Special Breakfast Symposium presented by
AMGEN
Chair: P.D. MILLER

Introduction and Opening Remarks
P.D. MILLER

Optimizing Osteoporosis Therapy: Current Options and Future Directions
P.D. MILLER

Clinical Implications of Abnormalities in the RANK/RANKL/OPG Pathway
L.C. HOFBAUER

RANKL Inhibition as an Evolving Therapeutic Option Across the Bone Loss Continuum
M.M. LUCKEY

Q&A/Closing Remarks
P.D. MILLER
16:15 – 17:45

THEATRE
(ROOM A)

Long-term Management of Osteoporosis: The Quest for Real-world Effectiveness

Satellite Symposium presented by
NOVARTIS
Co-chairs: S. ADAMI and J. BROWN

Introduction and Opening Remarks
S. ADAMI and J. BROWN

New Challenges in Osteoporosis in the 21st Century
E. SIRIS

Mechanisms and Utility of Bisphosphonates in Metabolic Bone Diseases
S. PAPAPOULOS

Efficacy of Long-acting Bisphosphonates in Metabolic Bone Diseases
J. ADACHI

Closing Remarks
S. ADAMI and J. BROWN
16:15 – 17:45

CONSTITUTION HALL
(ROOM B)

Redressing the Balance in Postmenopausal Osteoporosis

Satellite Symposium presented by
SERVIER
Co-chairs: H. GENANT and R. JOSSE

Introduction
R. JOSSE

Bone Biology and its Modulation
G. RUSSELL

Strontium Ranelate's Dual Action: A Closer Look
P.J. MARIE

A Broad Range of Antifracture Efficacy
E. SEEMAN

Meeting the Needs of Osteoporotic Patients
S. BOONEN

Conclusion
H. GENANT

Monday June 5, 2006

07:00 – 08:30

THEATRE
(ROOM A)

Beyond Conservative Care: Minimally Invasive Treatment for Vertebral Compression Fractures

Special Breakfast Symposium presented by
KYPHON

Is Conservative Management Conservative? The Impact of Vertebral Body Compression Fractures Treated Non-operatively on Health and Quality of Life
S. BOONEN

Minimally Invasive Surgery for VCFs: Indications, Contraindications and Outcomes
E. TRUMEES

Fracture Reduction Evaluation (FREE) – Update on Multi-center Prospective Randomized Controlled Clinical Trial Comparing Balloon Kyphoplasty to Non-surgical Management
D. WARDLAW
16:15 – 17:45

THEATRE
(ROOM A)

Clinical Perspectives: Use of Anabolic Therapy in the Management of Osteoporosis

Satellite Symposium presented by
NPS PHARMACEUTICALS
Chair: J.P. BILEZIKIAN

Welcome/Opening Remarks
J.P. BILEZIKIAN

Fracture Risk: Identifying Patients for Therapeutic Intervention
S. SILVERMAN

Parathyroid Hormone and Bone Health
R. HEANEY

Clinical Considerations and Optimization of Anabolic Therapy
J.P. BILEZIKIAN

Panel Discussion/Q&A
16:15 – 17:45

CONSTITUTION HALL
(ROOM B)

The Development of Tibolone for Prevention and Treatment of Osteoporosis in Postmenopausal Women

Satellite Symposium presented by
ORGANON
Co-chairs: R. LINDSAY and M. MOL

Management of Osteoporosis and Emerging New Treatment Options in Postmenopausal Women
R. LINDSAY

Preclinical Tibolone Research on Bone: Mechanism of Action, Bone Strength and Quality
T. EDERVEEN

The Tissue Selective Clinical Profile of Tibolone: Efficacy and Safety
J.C. GALLAGHER

Design of Tibolone Fracture Trial (LIFT) and Comparative Data versus Raloxifene (STEP)
P.D. DELMAS

Page Top